Innovation Norway – the State and the county authorities’ instrument for achieving value-creating business development – has allocated pre-project funds to PubGene to investigate how COREMINE Medical can be used to identify “state of art” information when unforeseen health challenges (such as Covid-19) emerge. The Covid-19 pandemic has shown us how vulnerable the global community is, and how important decisions need […]
PubGene has had dialogue with Norwegian health authorities on a possible role for establishing an information channel on the COVID-19 virus, with continuous update on status for the development of vaccines, treatments and documentation of preventive actions in society.
PubGene’s project proposal ‘Coremine Vitae: Realising the promise of precision medicine for cancer patients and their healthcare providers with biomedical intelligence reporting’ submitted for the European Innovation Council (EIC) Accelerator programme has received the Horizon 2020 Seal of Excellence, both at the January and the March cut-offs, confirming that the proposal passed all evaluation thresholds. Objectives for the […]
PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs.
Coremine Medical upgrade
The Coremine Medical service is upgraded with new features. Please register to the service here: https://coremine.com/medical/
CEO Håvard Hauge presented PubGene and Coremine Vitae at EHiN – Norway’s e-health conference – gathering 1650 national and international delegates. The audience was researchers and people working in healthcare, health informatics, governmental leaders and decision makers.
Agreement with Moloklinikken AS
PubGene has signed an innovation contract with the medical clinic Moloklinikken AS. The main objective is to define, develop and streamline the Coremine Vitae biomedical intelligence report as a combined personalised medicine information tool and service. Working with a private clinic like Moloklinikken provides an efficient opportunity to design a new product, since they play […]
PubGene collaborates with the Section for Research and Innovation at Haukeland University Hospital. Haukeland facilitates increased quality and quantity of clinical research, so that the health services can provide a better offer to the population in a cost-effective way. Haukeland provides feedback on the Coremine Vitae (CMV) product, and clinically validates and document its added […]
Nansen Neuroscience Network is a non-profit life science organization which are set up to accelerate innovation from Nordic neuroscience research. Much of the work is centred on creating arenas that can trigger synergies between basic and clinical researchers, and where academia and industry can meet and work together. PubGene focus has been primarily on the […]
On the 1 of April 2019, PubGene Chair of the Board Eirik Næss-Ulseth met with the State Secretary in the Ministry of Health Anne Grethe Erlandsen. Mr. Næss-Ulseth presented the Coremine Vitae biomedical intelligence report and received very positive feedback. The ministry wanted to be kept updated on the further developments of Coremine Vitae.